NCT02856347View on ClinicalTrials.gov

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 22, 2017

Primary Completion Date

December 20, 2020

Study Completion Date

December 20, 2020

Conditions
Medullary Thyroid Cancer
Interventions
OTHER

18F-DOPA

Injection of 18F-DOPA and PET / CT-scan assessment

Trial Locations (5)

31059

Institut Claudius Regaud, Toulouse

Unknown

CHU Haut-Lévêque, Bordeaux

CHU Limoges, Limoges

CHU Timone, Marseille

ICM Montpellier, Montpellier

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT02856347 - Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin | Biotech Hunter | Biotech Hunter